Costi ed efficacia della cura della schizofrenia con antipsicotici tipici e atipici

Autor:	R. Bezzi, Vittorio Mapelli, A. Erlicher, A. Lora, P. Miragoli
Rok vydání:	2004
Předmět:	medicine.medical_specialty business.industry Health Policy medicine.medical_treatment Pharmacy medicine.disease Mental illness Residential care Schizophrenia mental disorders medicine Pharmacology (medical) Antipsychotic Psychiatry business
Zdroj:	PharmacoEconomics Italian Research Articles. 6:15-30
ISSN:	2035-6137 1590-9158
DOI:	10.1007/bf03320619
Popis:	Introduction Schizophrenia is a ravaging and costly mental illness. Treatment of schizophrenia is long term and involves different kinds of care (drugs, outpatient, hospital, and residential care). Antipsychotic drugs contribute substantially to control patients positive and negative symptoms. In the late 90’s, new “atypical” antipsychotics have been introduced, which are supposed to be more effective, but also are more expensive. However evidence on cost-effectiveness of atypical drugs is yet limited.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::11585cfb49e8d9ad999d4226af1fcba1 https://doi.org/10.1007/bf03320619 Zobrazit plný text záznamu Full text from SpringerLink